Skip to main content
Cold and flu season Temporada de influenza y resfriados

ALERT: Stay healthy this cold and flu season! Learn more

ALERTA: ¡Mantente sano durante esta temporada de influenza y resfriados! Más información

New Website! ¡Nuevo sitio web!

ALERT: We have made the Texas Children’s Health Plan website even easier to use! Click here to learn more.

ALERTA: ¡Ahora el sitio web de Texas Children’s Health Plan es aún más sencillo de usar! Haz clic aquí para más información.

Enfamil shortage updates Escasez de Enfamil Reguline

ALERT: Shortage of Enfamil products until October 31, 2024. Learn more.

ALERTA: Escasez de productos de Enfamil hasta el 31 de octubre de 2024. Más información.

Change Healthcare Incident Change Healthcare incidente

Updates to Prior Authorization Requirements for CADs, electronic bone growth stimulators, home telemonitoring, and hospital beds

Attention: All providersEffective Date: February 1, 2021Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event.  TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event.Call to action: Texas Children’s Health Plan (TCHP) would like to inform network providers of Prior Authorization updates. Clinician Administered Drugs (CAD) that require a prior authorization effective February 1, 2021:
  • 90378, Synagis- for all members, available through the pharmacy benefit
  • J1746    Injection, ibalizumab-uiyk, 10 mg (Trogarzo)
  • J3397    Injection, vestronidase alfa-vjbk, 1 mg (Mepsevii)
  • J9269    Injection, tagraxofusp-erzs, 10 mcg (Elzonris)
  • J0129    Injection, abatacept, 10 mg (Orencia)
  • J0220    Injection, alglucosidase alfa, 10 mg, not otherwise specified
  • J0221    Injection, alglucosidase alfa, (Lumizyme), 10 mg
  • J0517    Injection, benralizumab, 1 mg   (Fasenra)
  • J9027    Injection, clofarabine, 1 mg (Clolar)
  • J7311    Injection, fluocinolone acetonide, intravitreal implant (Retisert), 0.01 mg
  • J2357    Injection, omalizumab, 5 mg  (Xolair)
  • J2786    Injection, reslizumab, 1 mg  (Cinqair)
Electronic Bone Growth Stimulators that require a prior authorization effective February 1, 2021:
  • E0749 Osteogenesis stimulator, electrical, surgically implanted
  • E0760 Osteogenesis stimulator, low intensity ultrasound, noninvasive
How this impacts providers: Providers should follow the new prior authorization guidelines and submit the requests for coverage timely to ensure payment. The turnaround time for routine requests is three business days. Next steps for providers: Providers should inform their staff of the new prior authorization requirements. If you have any questions, please email Provider Network Management at: providerrelations@texaschildrens.org.For access to all provider alerts,log into: www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.